
|Podcasts|January 18, 2022
Emerging HIFU technology shows promise in men with prostate cancer
Author(s)Urology Times staff
“It's really become the epicenter of all the surgeries that we do in urology,” says Jennifer Linehan, MD.
Advertisement
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Jennifer Linehan, MD. She discusses the role that high-intensity focused ultrasound (HIFU) has played among other minimally invasive and robotic technologies to mitigate the side effects and complications of treatment for prostate cancer, compared toe other treatment options. Linehan is an associate professor of urology and urologic oncology at the John Wayne Cancer Institute in Santa Monica, California.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
3
Farah Rahman, MD, on monitoring resident wellness using biofeedback
4
John Sfakianos, MD, on dual immune checkpoint inhibition in NMIBC
5






